Using Weed to Quit Opioids: The Complicated Truth

Situations Deep

9%

Cannabis shows real promise for easing opioid withdrawal symptoms, but it carries a 9% dependence risk of its own and is not a proven replacement for medication-assisted treatment.

International Journal of Drug Policy, 2019

International Journal of Drug Policy, 2019

View as image

If you are searching for information about using weed for opioid withdrawal, you are likely in one of two situations. Either you are in the middle of opioid withdrawal right now and looking for anything that might take the edge off, or you are trying to plan ahead for a taper or quit attempt and wondering whether cannabis could help. Both situations deserve a straight answer rather than hype or scare tactics. The research on this topic is genuinely promising in some areas and genuinely incomplete in others, and understanding where those lines fall could shape your decisions in meaningful ways.

This is not about whether cannabis is "good" or "bad." It is about whether it can serve a specific, limited role in one of the most difficult medical situations a person can face. The answer is more nuanced than either side of the debate usually admits.

Why People Reach for Cannabis During Opioid Withdrawal

Situations Deep

Cannabis for Opioid Withdrawal: What the Evidence Actually Supports

Population DataSuggestive

States with medical cannabis laws saw 24.8% fewer opioid overdose deaths

Correlation, not causation — other policy factors may contribute

JAMA Internal Medicine, 2014

Self-ReportModerate

1 in 4 people who use drugs reported using cannabis specifically for harm reduction

Lived experience, not controlled study — selection bias possible

Intl J Drug Policy, 2019

CBD ClinicalPromising

CBD reduced craving and anxiety in heroin use disorder for up to 7 days

Small sample, short duration, controlled conditions

Am J Psychiatry, 2019

THC ClinicalPreliminary

Limited controlled trials — most evidence is observational or preclinical

Cannot prescribe THC for opioid withdrawal with same confidence as buprenorphine/methadone

Neurotherapeutics, 2009

Critical Risks

Trading one dependence for another— ~9% of cannabis users develop dependence

Delaying proven treatment— MAT (buprenorphine/methadone) remains gold standard

False sense of security— Cannabis does not block opioid overdose

Bottom line: Cannabis may play a limited harm-reduction role alongside medical supervision, but it is not a proven standalone treatment. Anyone considering this approach needs a doctor involved — not instead of one.

Am J Psychiatry (2019) • JAMA Internal Medicine (2014)Cannabis for Opioid Withdrawal: What the Evidence Actually Supports

Opioid withdrawal is intensely physical. The symptoms include severe muscle aches, cramping, diarrhea, vomiting, sweating, insomnia, and restlessness so profound that the phrase "kicking the habit" comes from the involuntary leg movements it produces. While opioid withdrawal is rarely life-threatening on its own in otherwise healthy adults, the comparison to other withdrawal syndromes shows that it ranks among the most physically miserable experiences a person can endure.

The misery is not just the problem. It is the mechanism that drives relapse. When a person knows that a single dose of their opioid will make the suffering stop within minutes, the withdrawal itself becomes the biggest obstacle to quitting. This is why people look for anything that might reduce the intensity enough to get through it.

Cannabis enters this picture because of how it interacts with the body's endocannabinoid system (a network of receptors and chemical signals that helps regulate pain, mood, appetite, and sleep). THC and CBD both act on this system, and several of the symptoms that opioid withdrawal produces, including pain, nausea, insomnia, and anxiety, overlap with symptoms that cannabinoids have shown some ability to modulate.

What the Research Actually Shows

The evidence on cannabis for opioid withdrawal falls into three categories: population-level data, clinical observations, and preclinical research. Each tells a different part of the story.

Population-Level Findings

At the population level, the data is intriguing. A 2014 study by Bachhuber and colleagues published in JAMA Internal Medicine found that states with medical cannabis laws had a 24.8% lower average rate of opioid overdose deaths compared to states without those laws. A separate analysis found that opioid prescription rates dropped by 14 to 35% in states with medical cannabis access.

These numbers suggest that when cannabis is available, some people use less opioids. But correlation is not causation. These state-level analyses cannot tell you whether the specific people using cannabis were the same people who reduced their opioid use. Other factors, including broader policy changes and differences in healthcare access, could contribute to the patterns.

The Vancouver Study

One of the most direct pieces of evidence comes from Vancouver, Canada. A study published in the International Journal of Drug Policy found that approximately 1 in 4 people who use drugs reported using cannabis specifically as a harm reduction strategy. Many described using cannabis to manage withdrawal symptoms, reduce cravings, and decrease their use of substances with higher overdose risk.

This was not casual recreational use that happened to displace opioids. These were deliberate choices by people navigating serious substance use who found that cannabis, from their lived experience, made the process more manageable.

Clinical and Preclinical Evidence

A 2019 study published in the American Journal of Psychiatry found that CBD, the non-intoxicating compound in cannabis, reduced cue-induced craving and anxiety in people with heroin use disorder. Participants who received CBD showed significantly lower craving responses when exposed to drug-related cues compared to those who received a placebo. The effect persisted for up to seven days after the last CBD dose.

Animal studies have also shown that cannabinoids can reduce opioid self-administration and withdrawal severity in controlled settings. A 2009 review published in Neurotherapeutics examined interactions between the opioid and endocannabinoid systems and found significant overlap, suggesting biological plausibility for cannabis-based interventions.

These findings are promising. They are also preliminary. Most of the clinical studies involve small sample sizes, short durations, and controlled conditions that do not reflect real-world use. The science has not yet reached the point where a doctor can write a cannabis prescription for opioid withdrawal with the same confidence they prescribe buprenorphine or methadone.

What Cannabis Cannot Do

This is the section that matters most, and it is the part that gets left out of most conversations about weed and opioids.

It Is Not a Replacement for Medication-Assisted Treatment

Medication-assisted treatment, or MAT, uses medications like buprenorphine (Suboxone), methadone, or naltrexone to stabilize the brain's opioid system during recovery. MAT is the gold standard for opioid use disorder. A 2020 analysis published in The Lancet found that MAT reduces all-cause mortality in people with opioid use disorder by more than 50%.

Cannabis does not do this. No study has shown that cannabis reduces opioid overdose death risk at the individual level the way MAT does. No study has demonstrated that cannabis stabilizes opioid receptors or prevents the tolerance drop that makes post-relapse overdose so dangerous.

If you are dealing with opioid dependence and considering your options, MAT is the approach with the strongest evidence behind it. Cannabis might play a supporting role alongside MAT for some people, but substituting cannabis for evidence-based medical treatment is a gamble the research does not support.

It Carries Its Own Dependence Risk

Approximately 9% of people who use cannabis develop cannabis use disorder. For daily users, that number rises to roughly 25 to 30%. Trading opioid dependence for cannabis dependence is a meaningful harm reduction step because cannabis does not carry overdose fatality risk. But it is not the same as being free from substance dependence.

Cannabis withdrawal is real. It includes irritability, insomnia, appetite changes, anxiety, and restlessness. It is not medically dangerous in the way opioid relapse can be, but it is a genuine syndrome that can affect quality of life and functioning.

If you are using cannabis to manage opioid withdrawal with the goal of eventually being substance-free, it is worth having an honest plan for how you will address the cannabis use itself down the line. Using one substance to bridge away from another can work, but only if you recognize the bridge as temporary.

It Does Not Address the Underlying Drivers

Opioid use disorder is rarely just about the substance. Chronic pain, trauma, mental health conditions, and social circumstances all feed into the cycle. Cannabis might reduce withdrawal symptoms enough to get through the acute phase, but it does not treat chronic pain as effectively as a comprehensive pain management plan. It does not process trauma. It does not address the conditions that made opioids feel necessary in the first place.

For more on this pattern of self-medicating with weed, the underlying dynamic is the same regardless of which substance came first. Sustainable recovery usually involves addressing the root causes, not just swapping the chemical layer on top.

The Harm Reduction Perspective

Harm reduction is a public health framework that prioritizes reducing the worst consequences of substance use rather than demanding abstinence as the only acceptable outcome. From this perspective, cannabis as an opioid substitute makes mathematical sense.

Opioid overdose kills roughly 80,000 people per year in the United States. Cannabis overdose deaths: effectively zero. The gap in lethality is not small. It is enormous. For a person who is going to use a substance regardless of advice, cannabis is objectively less dangerous than fentanyl, heroin, or high-dose prescription opioids.

This does not make cannabis harmless. It means that in the specific context of harm reduction versus more dangerous substances, the risk comparison is not close. The conversation changes when the alternative is not abstinence but continued opioid use.

Online recovery communities reflect this reality. People describe using cannabis to take the edge off withdrawal symptoms during tapers, to manage cravings in early recovery, and to replace the ritualistic element of substance use with something less likely to kill them. These are not controlled studies. They are lived experiences from people making survival-level decisions with imperfect options.

If You Are Considering This Path

If you are thinking about using cannabis to help manage opioid withdrawal or reduce opioid use, consider these points.

Talk to a doctor first. Ideally, one who specializes in addiction medicine. They can help you understand how cannabis might interact with any medications you are taking, including MAT medications. Some combinations carry risks that are not obvious without clinical knowledge.

Do not skip MAT. If you qualify for buprenorphine, methadone, or naltrexone, those medications have decades of evidence showing they save lives. Cannabis does not have that evidence base yet. Consider cannabis as a potential supplement to medical treatment, not a replacement for it.

Be honest with yourself about dependence. If you are using cannabis daily to manage cravings or withdrawal symptoms, monitor your relationship with it. The 10 lower-risk cannabis use guidelines can help you keep your use within a range that minimizes the chance of developing a new dependency. Set a timeline for reassessment. The goal is to move toward stability, not to trade one daily substance for another indefinitely.

Consider CBD specifically. The American Journal of Psychiatry study on CBD and heroin craving used CBD, not THC. If craving reduction is your goal, CBD may offer some of the benefit without the intoxication, impairment, or the higher dependence risk that comes with THC.

Keep moving toward the root causes. Pain management, mental health treatment, trauma processing, and stable social supports are the foundations of lasting recovery. Cannabis might make the early phase more survivable, but it is not the destination.

When to Seek Professional Help

If you are experiencing opioid withdrawal, you do not have to go through it alone. Medical professionals can make the process significantly safer and more manageable, particularly through MAT.

If you are in crisis, experiencing thoughts of self-harm, or worried about relapse to opioids, reach out immediately.

SAMHSA National Helpline: 1-800-662-4357 (free, confidential, available 24/7)

Crisis Text Line: Text "HELLO" to 741741

These services connect you with local treatment resources and immediate support at no cost. Opioid use disorder is a medical condition, and effective treatment exists.

The Complicated Truth

The relationship between cannabis and opioid recovery is genuinely complicated, and the honest answer is that the science has not fully caught up with the question. Population-level data suggests cannabis access reduces opioid harms. Individual-level research shows CBD can reduce cravings. Lived experience from recovery communities suggests cannabis helps some people get through the worst of withdrawal. None of this adds up to "weed cures opioid addiction."

What it adds up to is something more modest and more honest. Cannabis may be a useful tool in a larger toolkit for some people in specific circumstances. It is not a magic solution. It is not a substitute for medical treatment. And it is not risk-free. But in a crisis where the alternative is continued opioid use or unsupervised withdrawal with a high probability of relapse, the research suggests it deserves a place in the conversation rather than being dismissed outright.

Understanding these nuances, including the difference between cross-addiction patterns and intentional harm reduction, puts you in a better position to make informed decisions about your own recovery. And informed decisions, made with medical support, are consistently the ones that lead to better outcomes.

The Bottom Line

Cannabis for opioid withdrawal shows promise but is not a proven standalone treatment. Population-level: Bachhuber 2014 (JAMA Internal Medicine) — states with medical cannabis laws had 24.8% lower opioid overdose death rates; opioid prescriptions dropped 14-35% in medical cannabis states (correlation, not confirmed causation). Direct evidence: Vancouver International Journal of Drug Policy study — 1 in 4 drug users reported using cannabis specifically as harm reduction for opioid withdrawal/cravings. Clinical: 2019 American Journal of Psychiatry — CBD reduced cue-induced craving and anxiety in heroin use disorder, effects persisting 7 days after last dose. Preclinical: 2009 Neurotherapeutics review — significant overlap between opioid and endocannabinoid systems supports biological plausibility. Critical limitations: not a replacement for MAT (buprenorphine/methadone/naltrexone) — 2020 Lancet analysis showed MAT reduces all-cause mortality by 50%+, no comparable evidence for cannabis. Cannabis carries its own dependence risk (~9% overall, 25-30% for daily users). Does not address underlying drivers (chronic pain, trauma, mental health). Harm reduction perspective: opioid overdose kills ~80K/year in US vs effectively zero cannabis overdose deaths — the lethality gap makes substitution mathematically rational when alternative is continued opioid use. Practical guidance: pursue MAT first, consider cannabis as supplement not replacement, discuss with addiction medicine specialist, monitor for cannabis dependence development, consider CBD specifically for craving reduction.

Frequently Asked Questions

Can weed help with opioid withdrawal symptoms?

Some research suggests cannabis may help reduce certain opioid withdrawal symptoms, including pain, nausea, insomnia, and anxiety. A 2019 study in the American Journal of Psychiatry found that CBD specifically reduced cue-induced cravings in people with heroin use disorder. However, cannabis is not a proven withdrawal treatment and does not replace medication-assisted treatment, which remains the most effective approach for opioid use disorder.

Is it safe to use cannabis while on Suboxone or methadone?

Cannabis can interact with MAT medications, and the safety profile depends on individual factors including dosage, frequency, and other health conditions. Some treatment programs allow cannabis use alongside MAT while others do not. You need to discuss this with your prescribing physician, who can assess the risks specific to your situation. Do not combine substances without medical guidance.

Is replacing opioids with weed just trading one addiction for another?

From a harm reduction perspective, cannabis dependence is significantly less dangerous than opioid dependence because cannabis carries no fatal overdose risk while opioids kill roughly 80,000 Americans per year. About 9% of cannabis users develop cannabis use disorder, which involves real withdrawal symptoms, but these are not life-threatening. Whether this trade-off is acceptable depends on your goals and circumstances, and it is best evaluated with a healthcare provider.

Does CBD work better than THC for opioid cravings?

The strongest clinical evidence specifically supports CBD. The 2019 American Journal of Psychiatry study used CBD isolate, not THC, and found significant reductions in craving and anxiety. CBD does not produce intoxication and carries a lower dependence risk than THC. However, research is still limited, and more large-scale clinical trials are needed before definitive recommendations can be made.

Do states with legal weed have fewer opioid deaths?

A 2014 study in JAMA Internal Medicine found that states with medical cannabis laws had 24.8% lower average opioid overdose death rates compared to states without those laws. Subsequent research has shown mixed results, with some later analyses finding the effect may be smaller or more complicated than initially reported. The relationship is real but complex, and researchers continue to debate whether cannabis access directly causes the reduction or reflects other policy and demographic differences.

How long can cannabis be used as a bridge during opioid recovery?

There is no established clinical guideline for this because cannabis is not an FDA-approved treatment for opioid use disorder. People who use cannabis as a bridge typically do so during the acute withdrawal phase (first 1-2 weeks) and early recovery period. If cannabis use becomes daily and indefinite, it may develop into its own dependence pattern. Setting a timeline with your healthcare provider, regularly reassessing whether cannabis is still serving a transitional purpose, and having a plan for eventually addressing cannabis use itself are all important parts of an honest harm reduction approach.